_version_ 1784905843046612992
author Abdallah, Mostafa
McCullough, Kristen
Ilyas, Rimal
Begna, Kebede H.
Al-Kali, Aref
Litzow, Mark R.
Hogan, William J.
Mangaonkar, Abhishek
Alkhateeb, Hassan
Shah, Mithun V.
Elliott, Michelle A.
Foran, James M.
Badar, Talha
Palmer, Jeanne M.
Yi, Cecilia Arana
Sproat, Lisa
Pardanani, Animesh
Patnaik, Mrinal M.
Olteanu, Horatiu
Ketterling, Rhett P.
Tefferi, Ayalew
Gangat, Naseema
author_facet Abdallah, Mostafa
McCullough, Kristen
Ilyas, Rimal
Begna, Kebede H.
Al-Kali, Aref
Litzow, Mark R.
Hogan, William J.
Mangaonkar, Abhishek
Alkhateeb, Hassan
Shah, Mithun V.
Elliott, Michelle A.
Foran, James M.
Badar, Talha
Palmer, Jeanne M.
Yi, Cecilia Arana
Sproat, Lisa
Pardanani, Animesh
Patnaik, Mrinal M.
Olteanu, Horatiu
Ketterling, Rhett P.
Tefferi, Ayalew
Gangat, Naseema
author_sort Abdallah, Mostafa
collection PubMed
description
format Online
Article
Text
id pubmed-10008821
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100088212023-03-14 Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Abdallah, Mostafa McCullough, Kristen Ilyas, Rimal Begna, Kebede H. Al-Kali, Aref Litzow, Mark R. Hogan, William J. Mangaonkar, Abhishek Alkhateeb, Hassan Shah, Mithun V. Elliott, Michelle A. Foran, James M. Badar, Talha Palmer, Jeanne M. Yi, Cecilia Arana Sproat, Lisa Pardanani, Animesh Patnaik, Mrinal M. Olteanu, Horatiu Ketterling, Rhett P. Tefferi, Ayalew Gangat, Naseema Blood Cancer J Correspondence Nature Publishing Group UK 2023-03-13 /pmc/articles/PMC10008821/ /pubmed/36907917 http://dx.doi.org/10.1038/s41408-023-00812-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Abdallah, Mostafa
McCullough, Kristen
Ilyas, Rimal
Begna, Kebede H.
Al-Kali, Aref
Litzow, Mark R.
Hogan, William J.
Mangaonkar, Abhishek
Alkhateeb, Hassan
Shah, Mithun V.
Elliott, Michelle A.
Foran, James M.
Badar, Talha
Palmer, Jeanne M.
Yi, Cecilia Arana
Sproat, Lisa
Pardanani, Animesh
Patnaik, Mrinal M.
Olteanu, Horatiu
Ketterling, Rhett P.
Tefferi, Ayalew
Gangat, Naseema
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
title Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
title_full Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
title_fullStr Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
title_full_unstemmed Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
title_short Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
title_sort abnormal karyotype is an independent predictor of inferior survival in blastic plasmacytoid dendritic cell neoplasm (bpdcn)
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008821/
https://www.ncbi.nlm.nih.gov/pubmed/36907917
http://dx.doi.org/10.1038/s41408-023-00812-y
work_keys_str_mv AT abdallahmostafa abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT mcculloughkristen abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT ilyasrimal abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT begnakebedeh abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT alkaliaref abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT litzowmarkr abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT hoganwilliamj abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT mangaonkarabhishek abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT alkhateebhassan abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT shahmithunv abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT elliottmichellea abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT foranjamesm abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT badartalha abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT palmerjeannem abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT yiceciliaarana abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT sproatlisa abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT pardananianimesh abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT patnaikmrinalm abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT olteanuhoratiu abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT ketterlingrhettp abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT tefferiayalew abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn
AT gangatnaseema abnormalkaryotypeisanindependentpredictorofinferiorsurvivalinblasticplasmacytoiddendriticcellneoplasmbpdcn